Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06171607 | Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses | recruiting | Phase 1 | 100 | University of Southern CaliforniaOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT06455904 | Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study(PROTECT-07) | recruiting | N/A | 156 | Centre Paul StraussOTHER | 1 | Feb 2, 2026 |
| NCT07377279 | Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients | recruiting | N/A | 384 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07380971 | Developing a Comprehensive Exercise Service for Breast Cancer Process | recruiting | — | 200 | GO fit Lab- IngesportNETWORK | 1 | Feb 2, 2026 | clinicaltrials |
| NCT02338167 | Praegnant Breast Cancer: Early/Advanced/Metastatic(PRAEGNANT) | recruiting | — | 13,500 | University Hospital TuebingenOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT03769415 | Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA(HARMONY) | recruiting | N/A | 500 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT05439005 | Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.(OFOBA) | recruiting | Phase 3 | 158 | Institut CurieOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT06097156 | Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications | recruiting | — | 45 | Tethis S.p.A.INDUSTRY | 1 | Jan 30, 2026 | clinicaltrials |
| NCT06926920 | A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer | recruiting | Phase 1 / Phase 2 | 100 | Gilead SciencesINDUSTRY | 3 | Jan 30, 2026 | clinicaltrials |
| NCT01503190 | The Immune System's Response to Young Women's Breast Cancer | recruiting | — | 800 | University of Colorado, DenverOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT04150042 | SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells(SHARON) | recruiting | Phase 1 | 24 | General Oncology, Inc.INDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT04680715 | Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer(RPOS+2) | recruiting | Phase 2 | 40 | Centre Antoine LacassagneOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06459791 | Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)(AVATAR) | recruiting | N/A | 110 | Institut CurieOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06534125 | Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer | recruiting | N/A | 150 | Emory UniversityOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376174 | The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy | recruiting | — | 300 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT03804944 | Converting HR+ Breast Cancer Into an Individualized Vaccine(CBCV) | recruiting | Phase 2 | 100 | Weill Medical College of Cornell UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05652569 | CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer(CATCH) | recruiting | — | 5,000 | German Cancer Research CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06371768 | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors(AYA STEPS) | recruiting | N/A | 260 | Duke UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06704945 | No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy(Neo-NAUTILUS) | recruiting | Phase 3 | 464 | Seoul National University HospitalOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT04371913 | Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study(Second Chance) | recruiting | N/A | 120 | Weill Medical College of Cornell UniversityOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT06715826 | Target-specific immunoPET Imaging of Breast Cancer | recruiting | Phase 1 / Phase 2 | 200 | RenJi HospitalOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07297134 | PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer(PTEN-miR-MBC) | recruiting | — | 160 | Atlas UniversityOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07371208 | Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer(ST-A-TN) | recruiting | Phase 2 | 40 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT03321045 | Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness | recruiting | Early Phase 1 | 10 | University of Alabama at BirminghamOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT05921253 | Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy(OU-SCC-NCAN) | recruiting | Early Phase 1 | 104 | University of OklahomaOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT06324240 | Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer | recruiting | Phase 1 | 18 | Emory UniversityOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07024173 | A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer | recruiting | Phase 3 | 240 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07208084 | Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer | recruiting | N/A | 90 | University of California, Los AngelesOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07365267 | Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy | recruiting | N/A | 25 | Xijing HospitalOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT04959474 | Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer | recruiting | N/A | 80 | Thomas Jefferson UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT05556473 | F-Tryptophan PET/CT in Human Cancers | recruiting | Phase 1 | 24 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07357311 | Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie(PDR-CARE) | recruiting | — | 200 | Institut CurieOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07362485 | Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)(INIGMA) | recruiting | N/A | 90 | Isabelle HenskensOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07362914 | Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions(CHORD) | recruiting | Phase 3 | 182 | Fudan UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT03863457 | [18F] F-GLN by PET/CT in Breast Cancer([18F]F-GLN) | recruiting | Phase 1 | 40 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06830889 | A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy | recruiting | Phase 3 | 1,450 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07358182 | Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer | recruiting | — | 300 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07358806 | Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 51 | Oscotec Inc.INDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT05736367 | Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer | recruiting | N/A | 16 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05909332 | Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) | recruiting | Phase 3 | 764 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06503783 | A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors | recruiting | Phase 1 | 20 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06609187 | A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors | recruiting | Phase 1 | 20 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06694519 | Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer | recruiting | N/A | 117 | SERGIO MONTERO NAVARROOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06718010 | The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer | recruiting | — | 120 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06957886 | A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer | recruiting | Phase 3 | 566 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07019363 | CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) | recruiting | Phase 3 | 1,903 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07291414 | A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients | recruiting | N/A | 80 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07354165 | Financial Toxicity in Patients With Early-stage Breast Cancer(VOICE - GIM36) | recruiting | — | 864 | National Cancer Institute, NaplesOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05366881 | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease(CAMPERR) | recruiting | — | 7,000 | Adela, IncINDUSTRY | 1 | Jan 20, 2026 | clinicaltrials |
| NCT05693766 | Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort(INSIGHT) | recruiting | Phase 2 | 64 | Sonya ReidOTHER | 1 | Jan 20, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Feb 2, 2026source: clinicaltrials